CEROW
CERo Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−26.92%Leverage
- Debt / equity
- -0.06x
- Net debt / equity
- 0.03x
- Debt / assets
- 0.27x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.01x
Liquidity & coverage
- Current ratio
- 0.14x
- Quick ratio
- 0.14x
- Cash ratio
- 0.08x
- Interest coverage
- -110.40x
- EBITDA / interest
- -108.08x
- Working capital
- -$9.8M
Cash & dividend
- FCF / debt
- -24.06x
- Cash flow / debt
- -24.06x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026